Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-0402
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
American Association for Cancer Research (AACR)